Gyre Therapeutics, Inc. (GYRE)
NASDAQ·Healthcare·Biotechnology
$4.57
-4.94%
Mkt Cap $425.20M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$17.00
Range $16.00 – $18.00
Implied Upside
+272.4%
Consensus $17.00 vs current $4.57
NASDAQ·Healthcare·Biotechnology
$4.57
-4.94%
Mkt Cap $425.20M
No recent rating data.
Price Target (2 analysts)
$17.00
Range $16.00 – $18.00
+272.4%
Consensus $17.00 vs current $4.57